Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Han

Showing results (461-470 of 490) with videos related to

Pageof 49
Sort By:
FEBS Letters|June 20, 2012
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancerHui-chan He, Jian-guo Zhu, Xi-bin Chen, et al.
Cell Communication and Signaling : CCS|April 26, 2024
DEC1 is involved in circadian rhythm disruption-exacerbated pulmonary fibrosisShuai-Jun Chen, Fan Yu, Xiao Feng, et al.
Frontiers in Oncology|May 13, 2025
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCCYu Li, Jian-Hong Zhong, Xiao-Dong Zhu, et al.
American Journal of Cancer Research|January 8, 2021
Oncogene <i>UBE2I</i> enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinomaXiang-Kun Wang, Xi-Wen Liao, Xin Zhou, et al.
Acta Pharmacologica Sinica|June 17, 2020
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinomaJi Feng, Pei-Zhi Lu, Guang-Zhi Zhu, et al.
American Journal of Cancer Research|April 6, 2019
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cellsYe Han, Mei-Kuang Chen, Hung-Ling Wang, et al.
BMC Cancer|June 19, 2012
SOXs in human prostate cancer: implication as progression and prognosis factorsWei-de Zhong, Guo-qiang Qin, Qi-shan Dai, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 18, 2026
Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancerJuan Wang, Tianjing Chang, Lili Tang, et al.
Elife|December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot studyGuanglei Chen, Xi Gu, Jinqi Xue, et al.
BMC Gastroenterology|December 11, 2020
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanismsJun-Qi Liu, Xi-Wen Liao, Xiang-Kun Wang, et al.
Pageof 49

Showing results (461-470 of 490) with videos related to

Sort By:
Pageof 49
FEBS Letters|June 20, 2012
MicroRNA-23b downregulates peroxiredoxin III in human prostate cancerHui-chan He, Jian-guo Zhu, Xi-bin Chen, et al.
Cell Communication and Signaling : CCS|April 26, 2024
DEC1 is involved in circadian rhythm disruption-exacerbated pulmonary fibrosisShuai-Jun Chen, Fan Yu, Xiao Feng, et al.
Frontiers in Oncology|May 13, 2025
Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCCYu Li, Jian-Hong Zhong, Xiao-Dong Zhu, et al.
American Journal of Cancer Research|January 8, 2021
Oncogene <i>UBE2I</i> enhances cellular invasion, migration and proliferation abilities via autophagy-related pathway resulting in poor prognosis in hepatocellular carcinomaXiang-Kun Wang, Xi-Wen Liao, Xin Zhou, et al.
Acta Pharmacologica Sinica|June 17, 2020
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinomaJi Feng, Pei-Zhi Lu, Guang-Zhi Zhu, et al.
American Journal of Cancer Research|April 6, 2019
Synergism of PARP inhibitor fluzoparib (HS10160) and MET inhibitor HS10241 in breast and ovarian cancer cellsYe Han, Mei-Kuang Chen, Hung-Ling Wang, et al.
BMC Cancer|June 19, 2012
SOXs in human prostate cancer: implication as progression and prognosis factorsWei-de Zhong, Guo-qiang Qin, Qi-shan Dai, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 18, 2026
Development and validation of a multiparametric magnetic resonance imaging-based nomogram for predicting feasibility of sphincter-preserving surgery in mid-low rectal cancerJuan Wang, Tianjing Chang, Lili Tang, et al.
Elife|December 22, 2023
Effects of neoadjuvant stereotactic body radiotherapy plus adebrelimab and chemotherapy for triple-negative breast cancer: A pilot studyGuanglei Chen, Xi Gu, Jinqi Xue, et al.
BMC Gastroenterology|December 11, 2020
Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanismsJun-Qi Liu, Xi-Wen Liao, Xiang-Kun Wang, et al.
Pageof 49